What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-30 compared with 2025-03-31 · 57 added, 36 removed, 2 unchanged (98% of the section changed)

FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

February 25, 2021, our common stock was delisted from The Nasdaq Capital Market and began trading on the OTCQX Best Market under the

symbol “IDXG.” OTCQX Best Market quotations reflect inter-dealer prices and may not necessarily represent actual transactions.

December 28, 2023, we received notice from the OTCQX indicating that the Company’s market capitalization has been below the required

$5 million for 30 consecutive calendar days preceding the date of such notice, and that the Company no longer meets the standards for

continued qualification for the OTCQX U.S.

MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Effective February 25, 2021,

our common stock was delisted from The Nasdaq Capital Market and began trading on the OTCQX Best Market under the symbol “IDXG.”

OTCQX Best Market quotations reflect inter-dealer prices and may not necessarily represent actual transactions.

On May 20, 2025, we received

notice from the OTCQX indicating that the Company’s market capitalization has stayed below the required $5 million for 30 consecutive

calendar days preceding the date of such notice, and that the Company no longer met the standards for continued qualification for the

tier under the OTCQX Rules for U.S.

Companies section 3.2.b.2.

On March 20, 2024 we received

notice from the OTCQX indicating that the Company’s market capitalization has stayed above the required $5 million for ten consecutive

trading days preceding the date of such notice, and that the Company currently satisfies the standards for continued qualification for

the OTCQX U.S.

tier under the OTCQX Rules for U.S.

Company may seek an uplisting of its common stock to Nasdaq, but no assurances can be given that a Nasdaq listing will be achieved.

had 184 stockholders of record as of March 21, 2025.

Not reflected in the number of stockholders of record are persons who beneficially

own shares of common stock held in nominee or street name.

have not declared any cash dividends and do not intend to declare or pay any cash dividends in the foreseeable future.

Future earnings,

if any, will be used to finance the future operation and growth of our businesses.

Sales of Equity Securities

October 10, 2024, we and the Investors entered into the Exchange Agreement pursuant to which the Company exchanged an aggregate of 47,000

shares of the Company’s existing Series B Preferred Stock, comprised of 28,000 shares of Series B Preferred Stock held by Ampersand

and 19,000 shares of Series B Preferred Stock held by 1315 Capital, which represented all of the Company’s issued and outstanding

Series B Preferred Stock, for 47,000 newly created shares of Series C Preferred Stock.

In the Exchange, Ampersand received 28,000 shares

of Series C Preferred Stock and 1315 received 19,000 shares of Series C Preferred Stock.

shares of Series C Preferred Stock issued in the Exchange were not registered under the Securities Act, and were issued in reliance on

the exemptions from registration provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder, for transactions

not involving a public offering.

connection with the Exchange, on October 10, 2024, the Company and the Investors entered the Amended and Restated Investor Rights Agreement.

Pursuant to the Amended and Restated Investor Rights Agreement, the Company and the Investors established certain terms and conditions

concerning the rights of and restrictions on the Investors with respect to the ownership of the Series C Preferred Stock of the Company.

Amended and Restated Investor Rights Agreement provides the Investors with (1) demand registration rights exercisable beginning on the

date of the Closing and subject to certain limitations described therein, (2) piggy-back registration rights at any time the Company

proposes to file a registration statement under the Securities Act, with respect to an offering of equity securities, or securities or

other obligations exercisable or exchangeable for, or convertible into, equity securities, subject to certain exceptions described therein,

and (3) shelf registration rights

The Company’s common stock was removed from quotation

on the OTCQX on August 18, 2025.

The Company’s common

stock is currently quoted on the OTCID ® tier of the OTC Markets Group Inc.

(the “OTCID”), an electronic quotation

service operated by OTC Markets Group Inc.

The Company intends to seek

an uplisting of its common stock to Nasdaq, but no assurances can be given that a Nasdaq listing will be achieved.

Holders of Record

We had 184 stockholders of

record as of March 2, 2026.

Not reflected in the number of stockholders of record are persons who beneficially own shares of common stock

held in nominee or street name.

We have not declared any

cash dividends and do not intend to declare or pay any cash dividends in the foreseeable future.

Future earnings, if any, will be used

to finance the future operation and growth of our businesses.

Unregistered Sales of Equity Securities

On October 10, 2024, we entered

into an Exchange Agreement with Ampersand and 1315 Capital, pursuant to which the Company exchanged an aggregate of 47,000 shares of the

Company’s existing Series B Preferred Stock, comprised of 28,000 shares of Series B Preferred Stock held by Ampersand and 19,000

shares of Series B Preferred Stock held by 1315 Capital, which represented all of the Company’s issued and outstanding Series B

Preferred Stock, for 47,000 newly created shares of Series C Preferred Stock.

In the exchange, Ampersand received 28,000 shares of Series

C Preferred Stock and 1315 Capital received 19,000 shares of Series C Preferred Stock.

The shares of Series C Preferred

Stock issued in the exchange were not registered under the Securities Act, and were issued in reliance on the exemptions from registration

provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder, for transactions not involving a public

In connection with the exchange,

on October 10, 2024, the Company entered into an Amended and Restated Investor Rights Agreement with Ampersand and 1315 Capital.

and Restated Investor Rights Agreement established certain terms and conditions concerning the rights of and restrictions on Ampersand

and 1315 Capital with respect to the ownership of the Series C Preferred Stock of the Company.

The Amended and Restated Investor Rights

Agreement provided the Investors with (1) demand registration rights subject to certain limitations described therein, (2) piggy-back

registration rights at any time the Company proposed to file a registration statement under the Securities Act, with respect to an offering

of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, subject

to certain exceptions described therein, and (3) shelf registration rights

On January 13, 2026, Ampersand

converted the 28,000 shares of Series C Preferred Stock it held into 13,861,386 shares of our common stock.

On January 15, 2026, 1315

Capital converted the 19,000 shares of Series C Preferred Stock it held into 9,405,941 shares of our common stock.

All shares of Series

C Preferred Stock were thereby converted, resulting in the issuance of an aggregate of 23,267,327 shares of Interpace common stock (calculated

as $1,000 stated value per preferred share divided by the $2.02 conversion price).

The shares of common stock

issued as a result of the conversions were not registered under the Securities Act, and were issued in reliance on the exemptions from

registration provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder, for transactions not involving

a public offering.

Use of Proceeds

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity